Related Experiment Video
Updated: Jul 10, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Group A rotavirus-associated diarrhea in children seeking treatment in Indonesia
Shannon D Putnam1, Endang R Sedyaningsih, Erlin Listiyaningsih
1U.S. Naval Medical Research Unit No. 2, Jakarta, Indonesia. putnam@namrutwo.org
Insights
Rotavirus is a major cause of childhood diarrhea in Indonesia, with prevalence at 45.5%. Genotyping revealed a shift to G9P[8], suggesting a multivalent vaccine could reduce illness burden.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Group A rotavirus is a leading cause of severe diarrhea and death in children globally.
- Epidemiological data on rotavirus disease in Indonesian children is scarce.
Purpose of the Study:
- To investigate the epidemiology of rotavirus-associated diarrhea in Indonesian children under six years old.
- To identify clinical symptoms and prevalent rotavirus genotypes.
Main Methods:
- A hospital-based case series study was conducted across four referral hospitals from February 2004 to February 2005.
- Rotavirus detection utilized enzyme immunoassay (EIA) and reverse transcription-polymerase chain reaction (RT-PCR).
- Specific rotavirus genotypes were determined using semi-nested RT-PCR.
Main Results:
- Out of 1660 stool samples tested, 45.5% were positive for rotavirus.
- Children with rotavirus diarrhea were younger and more likely to be hospitalized.
- Common symptoms included vomiting, fever, nausea, fatigue, and dehydration; bloody stools were less frequent.
Conclusions:
- Rotavirus significantly contributed to morbidity in the study population.
- A temporal shift in rotavirus genotypes from G1-G4 to G9 was observed, strongly associated with the P[8] gene.
- A multivalent rotavirus vaccine targeting G9P[8] may decrease the burden of diarrheal diseases in Indonesian children.
Background:
Globally, group A rotavirus causes significant morbidity and mortality among children. Limited data exist on the epidemiology of rotavirus disease among Indonesian children.
Objectives:
We describe the epidemiology of rotavirus-associated diarrhea among Indonesian children <6 years of age, including clinical symptoms and genotypes.
Study Design:
We conducted a hospital-based, case series study at four referral hospitals between February 2004 and February 2005 among children with diarrhea. Rotavirus positivity was defined by a positive result from either EIA or RT-PCR. A semi-nested RT-PCR was used to determine specific rotavirus genotypes.
Results:
1660 stools were tested for pathogens. The overall rotavirus prevalence was 45.5%. Children with rotavirus-associated diarrhea were significantly younger (p<0.0001) and more likely to be hospitalized (81.3% versus 72.2%; p<0.0001). Symptoms associated with rotavirus included, vomiting, fever, nausea, fatigue and dehydration, while bloody stool was significantly less common with rotavirus-associated diarrhea.
Conclusion:
Rotavirus was an important contributor of morbidity to our study sample. Rotavirus genotyping demonstrated a temporal shift from G1-G4 to G9, but this was highly associated with the P[8] gene, suggesting that a multivalent rotavirus vaccine, incorporating G9 P[8] antigen, may reduce the burden of diarrheal illnesses among Indonesian children.
Related Concept Videos
Bacterial Gastroenteritis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Poliomyelitis
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Cholera
Respiratory Syncytial Virus Disease
